In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of ...

For more information, see Section 1. Why am I using ISOPTIN injection? in the full CMI. Do not use if you have ever had an allergic reaction to ISOPTIN injection or any of the ingredients listed ...

Xolair, a drug developed 15 years ago by Roche and Novartis, received a breakthrough designation from the US regulator in a new food allergy indication. The Food and Drug Administration (FDA ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

Weight loss injections are becoming a popular option for those wanting to lose weight. Drugs like Mounjaro and Wegovy are now household names. NICE has approved Mounjaro for weight loss treatment ...

Novartis’ anti-IgE antibody Xolair (omalizumab) has been a mainstay of treatment for refractory CSU for many years. However, the drug is heading for patent expiry in Europe this year and in the ...

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

Expert Guidance — Created by Jack Wallen through 20 hours of research, ... Recruit the best information systems manager to oversee the reliable operation of MIS for your organization.

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 19 ...